Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
Urology Awareness Month
Primary neuroendocrine tumours in the genitourinary tract are rare, comprising approximately 1-2% of all genitourinary malignancies.
Neuroendocrine Cancer Treatments
There are a number of treatments available for Neuroendocrine Cancer – but your treatment should be based on your Neuroendocrine Cancer.
National COVID Cancer survey
Further to our News Item last week (15th Sept) - here is an update and the link required to get involved: National COVID Cancer survey To improve the understanding of the protection provided by antibodies generated following COVID-19 infection and vaccination in...